These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 11556053)

  • 1. Episodes in action: linking the cost and quality of nonsurgical coronary revascularization.
    Pine M
    Manag Care Q; 2001; 9(3):25-33. PubMed ID: 11556053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and economic effects of coronary restenosis after percutaneous coronary intervention in a managed care population.
    Clark MA; Bakhai A; Pelletier EM; Cohen DJ
    Manag Care; 2005 Apr; 14(4):42-4, 46-51. PubMed ID: 15898211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The response of physician groups to P4P incentives.
    Mehrotra A; Pearson SD; Coltin KL; Kleinman KP; Singer JA; Rabson B; Schneider EC
    Am J Manag Care; 2007 May; 13(5):249-55. PubMed ID: 17488190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penetrating the "black box": financial incentives for enhancing the quality of physician services.
    Conrad DA; Christianson JB
    Med Care Res Rev; 2004 Sep; 61(3 Suppl):37S-68S. PubMed ID: 15375283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining the length of stay following percutaneous coronary intervention: an expert consensus document from the Society for Cardiovascular Angiography and Interventions. Endorsed by the American College of Cardiology Foundation.
    Chambers CE; Dehmer GJ; Cox DA; Harrington RA; Babb JD; Popma JJ; Turco MA; Weiner BH; Tommaso CL;
    Catheter Cardiovasc Interv; 2009 Jun; 73(7):847-58. PubMed ID: 19425053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pay for performance for the allergist-immunologist: potential promise and problems.
    Schatz M; Blaiss M; Green G; Aaronson D
    J Allergy Clin Immunol; 2007 Oct; 120(4):769-75. PubMed ID: 17681367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial.
    Bakhai A; Stone GW; Mahoney E; Lavelle TA; Shi C; Berezin RH; Lahue BJ; Clark MA; Lacey MJ; Russell ME; Ellis SG; Hermiller JB; Cox DA; Cohen DJ;
    J Am Coll Cardiol; 2006 Jul; 48(2):253-61. PubMed ID: 16843171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Episodes of care: an overview of legal and regulatory issues.
    Krane DW; McNair RM; Greenwood BJ; Kramer KM
    Manag Care Q; 2001; 9(3):52-65. PubMed ID: 11556056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value-based insurance design: a "clinically sensitive" approach to preserve quality of care and contain costs.
    Fendrick AM; Chernew ME
    Am J Manag Care; 2006 Jan; 12(1):18-20. PubMed ID: 16402884
    [No Abstract]   [Full Text] [Related]  

  • 10. One-year clinical results and total costs of drug-eluting stents implantation in multivessel coronary artery disease.
    Varani E; Balducelli M; Vecchi G; Aquilina M; Maresta A
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):596-601. PubMed ID: 17667030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pay for performance in emergency medicine.
    Sikka R
    Ann Emerg Med; 2007 Jun; 49(6):756-61. PubMed ID: 16979264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicaid managed care program provides fiscal rewards for performance.
    Perform Improv Advis; 2005 Jul; 9(7):80-1, 73. PubMed ID: 16114483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case against low-volume percutaneous coronary intervention centers.
    O'Neill WW
    Circulation; 2009 Aug; 120(7):546-8. PubMed ID: 19652088
    [No Abstract]   [Full Text] [Related]  

  • 14. Medicare launches financial incentive program to reward hospital quality care.
    Qual Lett Healthc Lead; 2003 Aug; 15(8):12-6, 1. PubMed ID: 12961835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unfulfilled potential. More performance pay would improve care: NCQA.
    Fong T
    Mod Healthc; 2004 Sep; 34(39):12. PubMed ID: 15506505
    [No Abstract]   [Full Text] [Related]  

  • 16. Predictors of high-cost managed care patients with acute coronary syndrome.
    Etemad LR; McCollam PL
    Curr Med Res Opin; 2005 Dec; 21(12):1977-84. PubMed ID: 16368049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physician-level P4P--DOA? Can quality-based payment be resuscitated?
    McMahon LF; Hofer TP; Hayward RA
    Am J Manag Care; 2007 May; 13(5):233-6. PubMed ID: 17488186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing an IDS's readiness to operate profitably under a risk contract.
    Garofalo WA
    Healthc Financ Manage; 2001 Feb; 55(2):41-5. PubMed ID: 11271441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing costs and improving outcomes of percutaneous coronary interventions.
    Moscucci M; Muller DW; Watts CM; Bahl V; Bates ER; Werns SW; Kline-Rogers E; Karavite D; Eagle KA
    Am J Manag Care; 2003 May; 9(5):365-72. PubMed ID: 12744298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of coronary artery bypass grafts versus percutaneous coronary intervention for revascularization of high-risk patients.
    Stroupe KT; Morrison DA; Hlatky MA; Barnett PG; Cao L; Lyttle C; Hynes DM; Henderson WG;
    Circulation; 2006 Sep; 114(12):1251-7. PubMed ID: 16966588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.